-
Follow Us On:
-
-
CRT, or Cardiac Resynchronization Therapy, helps coordinate the pumping action of the heart in selected heart failure patients, and combination devices may also include defibrillator protection.
The device improves timing between the heart chambers to support more efficient pumping.
It is considered when heart failure symptoms continue along with conduction delay or dyssynchrony.
Some patients need a combo device that offers both resynchronization and defibrillator capability.
Treatment planning depends on ECG pattern, heart function, symptoms, and overall risk profile.
Patients with heart failure and reduced pumping function despite guideline-based medicine.
People with electrical dyssynchrony such as broad QRS patterns on ECG.
Cases where better chamber coordination may improve symptoms and reduce admissions.
Patients who may benefit from combined pacing and shock protection.
Implantation is followed by careful device optimisation and regular review.
Patients are monitored for change in symptoms, exercise capacity, and fluid status.
Follow-up includes rhythm checks, lead review, and adjustment of heart failure therapy.
Long-term success depends on coordinated device care and continued medical management.
Provides continuous support for heart rhythm or pumping function.
Reduces the risk of serious rhythm-related complications in suitable patients.
Improves confidence with regular monitoring, checks, and planned follow-up.
Supports better long-term heart performance and quality of life.
Consult our cardiology team to understand whether CRT / Combo Device is appropriate for your condition. Timely evaluation helps identify the right device plan, improve safety, and support better long-term heart function.
CRT, or Cardiac Resynchronization Therapy, helps coordinate the pumping action of the heart in selected heart failure patients, and combination devices may also include defibrillator protection. The device improves timing between the heart chambers to support more efficient pumping. It is considered when heart failure symptoms continue along with conduction delay or dyssynchrony. Some patients need a combo device that offers both resynchronization and defibrillator capability. Treatment planning depends on ECG pattern, heart function, symptoms, and overall risk profile.
Patients with heart failure and reduced pumping function despite guideline-based medicine. People with electrical dyssynchrony such as broad QRS patterns on ECG. Cases where better chamber coordination may improve symptoms and reduce admissions. Patients who may benefit from combined pacing and shock protection.
Implantation is followed by careful device optimisation and regular review. Patients are monitored for change in symptoms, exercise capacity, and fluid status. Follow-up includes rhythm checks, lead review, and adjustment of heart failure therapy. Long-term success depends on coordinated device care and continued medical management.
Provides continuous support for heart rhythm or pumping function. Reduces the risk of serious rhythm-related complications in suitable patients. Improves confidence with regular monitoring, checks, and planned follow-up. Supports better long-term heart performance and quality of life.